Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:IMLE

International Isotopes (IMLE) Stock Price, News & Analysis

International Isotopes logo

About International Isotopes Stock (NASDAQ:IMLE)

Advanced Chart

Key Stats

Today's Range
$0.89
$1.12
50-Day Range
$0.07
$3.00
52-Week Range
$0.00
$0.09
Volume
4.95 million shs
Average Volume
39,488 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TransBiotec, Inc. develops non-invasive alcohol sensing systems. It develops SOBR, a transdermal sensing system that detects blood alcohol levels through a person's skin. The company was founded in 2004 and is based in Santa Ana, California.

Receive IMLE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Isotopes and its competitors with MarketBeat's FREE daily newsletter.

IMLE Stock News Headlines

Is this the pin that pops the bubble?
CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia… In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers. Go here now before it’s too late to find out why Nvidia shares are slumping so hard.
See More Headlines

IMLE Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that International Isotopes investors own include Opera (OPRA), Mogo (MOGO), Energy Transfer (ET), Telefonaktiebolaget LM Ericsson (publ) (ERIC), Ecopetrol (EC) and DHT (DHT).

Industry, Sector and Symbol

Industry
Scientific & Technical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IMLE
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:IMLE) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners